Stay updated on Adaptive TKI Therapy in Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Adaptive TKI Therapy in Thyroid Cancer Clinical Trial page.

Latest updates to the Adaptive TKI Therapy in Thyroid Cancer Clinical Trial page
- Check6 days agoChange DetectedA new 'Locations' section lists Florida as a site, replacing the former 'Florida Locations' entry; the 'HHS Vulnerability Disclosure' link was removed.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.2.0 updated to v3.3.2. No visible changes to study content or page structure are evident in the screenshot.SummaryDifference0.0%

- Check42 days agoChange DetectedRemoved the government funding lapse notice from the page. The study details, eligibility criteria, and outcomes sections remain unchanged.SummaryDifference0.3%

- Check56 days agoChange DetectedNo significant updates were detected to the study page between versions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check85 days agoChange DetectedMajor update: publishing a government funding/status notice and upgrading to v3.2.0; removal of specific thyroid cancer resources (Medullary and Differentiated thyroid carcinoma) from the Genetic and Rare Diseases Information Center.SummaryDifference3%

- Check92 days agoChange DetectedTerminology updated fromSummaryDifference0.1%

Stay in the know with updates to Adaptive TKI Therapy in Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adaptive TKI Therapy in Thyroid Cancer Clinical Trial page.